期刊文献+

10例肝衰竭合并侵袭性真菌感染患者的临床分析 被引量:3

Analysis of 10 cases with liver failure complicated by invasive fungal infections
原文传递
导出
摘要 目的探讨肝衰竭合并侵袭性真菌感染(IFI)的诱因、诊断及治疗。方法对10例肝衰竭合并IFI的患者临床资料进行回顾性分析。结果10例IFI患者的感染部位:消化道占50%,呼吸道占33.3%,其它血液、腹腔各占8.3%。感染菌种主要为白色念珠菌(50%),其它热带念珠菌、光滑念珠菌及曲霉菌各占16.6%。本组病例IFI发病前80%的病例曾接受侵入性操作,全部患者有2种抗菌素用药史且疗程超过1周。10例IFI患者均接受抗真菌治疗,真菌感染治愈1例,好转2例,未愈7例,终因肝衰竭死亡8例。结论肝衰竭合并IFI病死率高、预后差。积极避免诱发因素,注重早预防、早诊断和及时治疗是降低这类患者病死率的重要环节。 Objective To study risk factor,diagnosis and therapy in patients with liver failure complicated by invasive fungal infections(IFI).Methods Ten patients with liver failure complicated by IFI was studied retrospectively.Results IFI of digestive tract accounted for 50%,that of respiratory tract,blood and abdominal cavity accounted for 33.3%,8.3%,8.3%,respectively.Candida albicans accounted for 50%,Candida tropicals,Candida glabrata and aspergillus accounted for 16.6%,individually.Use of broad-spectrum antibiotic and improper medical manipulations were significant risk factors.All of 10 cases received anti-fungal therapies and showed that 1 case cured and 2 alleviated.The mortality due to liver failure and IFI was 80%.Conclusions Risk factors of liver failure complicated by IFI should be avoided.Early prophylaxis,early diagnosis and appropriate therapy would be important for these patients.
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2007年第4期229-231,共3页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
关键词 侵袭性真菌感染 肝衰竭 抗真菌治疗 Invasive fungal infections Liver failure Anti-fungal therapy
  • 相关文献

参考文献3

二级参考文献25

  • 1周颖杰,李光辉.美国感染病学会念珠菌病治疗指南[J].中国感染与化疗杂志,2006,6(3):203-208. 被引量:5
  • 2Edwards JE, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infectious[J]. Clin Infect Dis, 1997,25:43-59.
  • 3National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility of yeast ; Approved standard M27A[ S]. Lancaster Avenue, villanova, pennsylvania: NCCLS, 1997.1-12.
  • 4Ptaller MA, Jones RV, Doern GV, et al. Bloodstream infectious due to candida species: SENTRY antimicrobial surveillance program in North America and Latin America[ J ]. Antimicrob Agents Chemother, 2000,44 :747-751.
  • 5Schwab U, Chemomas F, Larcom L, et al. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients [J ]. Diag Microbiol Infect Dis, 1997,29 : 11-17.
  • 6中华人民共和国卫生部医政司.全国临床检验操作规程[S].江苏:东南大学出版社,1997.540-548.
  • 7Clark TA,Hajjeh RA.Recent trends in the epidemiology of invasive mycoses[J].Curr Opin Infect Dis,2002,15(6):569-574.
  • 8Pfaller MA,Pappas PG,Wingard JR.Invasive fungal pathogens:current epidemiological trends[J].Clin Infect Dis,2006,43:S3-S14.
  • 9Wisplinghoff H,Bischoff T,Tallent SM,et al.Nosocomial bloodstream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309-317.
  • 10Kontoyiannis DP,Bodey GP.Invasive aspergillosis in 2002:an update[J].Eur J Clin Microbiol Infect Dis,2002,21(3):161-172.

共引文献107

同被引文献29

  • 1常东,蒋伟,黄志红,沈玉杰.真菌感染及耐药性分析[J].中华医院感染学杂志,2005,15(3):345-347. 被引量:52
  • 2李军体,孟凡义,孙竞,徐兵,刘晓力.恶性血液病合并侵袭性真菌感染73例治疗分析[J].中国实用内科杂志,2006,26(3):376-378. 被引量:23
  • 3血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610. 被引量:250
  • 4重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量:429
  • 5Zahida Bhatti,Aasma Shaukat,Nikolaos G. Almyroudis,Brahm H. Segal.Review of Epidemiology, Diagnosis, and Treatment of Invasive Mould Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients[J]. Mycopathologia . 2006 (1)
  • 6Dykewicz CA.Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients:focus on community respiratory virus infections. Biology of Blood and Marrow Transplantation . 2001
  • 7Lehrnbecher T,Frank C,Engels K,et al.Trends in the postmortem epidemiology of invasive fungal infections at a university hos-pital. Journal of Infection . 2010
  • 8Robenshtok E,Gafter-Gvili A,Goldberg E,et al.Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation:systematic review and meta-analysis. Journal of Clinical Oncology . 2007
  • 9Abraham C,Manavathu EK,Cutright JL,et al.In vitro susceptibilities of Aspergillus species to voriconazole,itraconazole,and amphotericin B. Diagnostic Microbiology and Infectious Disease . 1999
  • 10Auberger,J. et al.First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation. Diagnostic Microbiology and Infectious Disease . 2008

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部